Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
F127328-10mg | 10mg | In stock | $63.90 | |
F127328-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $127.90 | |
F127328-100mg | 100mg | In stock | $177.90 | |
F127328-500mg | 500mg | In stock | $129.90 | |
F127328-1g | 1g | In stock | $1,441.90 | |
F127328-5g | 5g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $6,488.90 |
Adenylyl cyclase activator
Synonyms | forskolin | Colforsin | 66575-29-9 | Coleonol | colforsina | colforsine | colforsinum | Boforsin | HL 362 | Coleonolk | L 75 1362B | (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-3-vinyldodecahydro-1H-benzo[f]chromen-5-yl acetate | Forskolin |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Forskolin is a diterpenoid isolated from Coleus forskohlii, interacts directly with the catalytic subunit of A cyclase (adenylate cyclase), activating the enzyme and raising intracellular levels of cAMP. Forskolin is cell permeable and active in vivo prod |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Product Description | Forskolin is a ubiquitous activator of eukaryotic adenylyl cyclase (AC), commonly used to raise levels of cAMP in the study and research of cell physiology. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
IUPAC Name | [(3R,4aR,5S,6S,6aS,10S,10aR,10bS)-3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl] acetate |
---|---|
INCHI | InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1 |
InChi Key | OHCQJHSOBUTRHG-KGGHGJDLSA-N |
Canonical SMILES | CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O |
Isomeric SMILES | CC(=O)O[C@H]1[C@H]([C@@H]2[C@]([C@H](CCC2(C)C)O)([C@@]3([C@@]1(O[C@@](CC3=O)(C)C=C)C)O)C)O |
WGK Germany | 3 |
RTECS | QL6150000 |
PubChem CID | 47936 |
Molecular Weight | 410.5 |
Beilstein | 1692720 |
CAS Registry No. | 66575-29-9 |
---|---|
DrugBank Ligand | DB02587 |
Wikipedia | Forskolin |
ChEBI | CHEBI:42471 |
PubChem CID | 47936 |
ChEMBL Ligand | CHEMBL52606 |
RCSB PDB Ligand | FOK |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
K2214108 | Certificate of Analysis | Aug 21, 2024 | F127328 |
J2214299 | Certificate of Analysis | Jul 05, 2024 | F127328 |
F2208133 | Certificate of Analysis | Mar 21, 2024 | F127328 |
K2327382 | Certificate of Analysis | Nov 08, 2023 | F127328 |
K2327374 | Certificate of Analysis | Nov 08, 2023 | F127328 |
K2327373 | Certificate of Analysis | Nov 08, 2023 | F127328 |
K2327231 | Certificate of Analysis | Nov 08, 2023 | F127328 |
K2129685 | Certificate of Analysis | Sep 15, 2023 | F127328 |
K2215085 | Certificate of Analysis | Nov 26, 2022 | F127328 |
C2226626 | Certificate of Analysis | May 24, 2022 | F127328 |
C2223026 | Certificate of Analysis | May 08, 2022 | F127328 |
F2208437 | Certificate of Analysis | Mar 24, 2022 | F127328 |
F2309060 | Certificate of Analysis | Mar 24, 2022 | F127328 |
B2316338 | Certificate of Analysis | Mar 24, 2022 | F127328 |
F2208319 | Certificate of Analysis | Mar 24, 2022 | F127328 |
F2208132 | Certificate of Analysis | Mar 24, 2022 | F127328 |
E2306665 | Certificate of Analysis | Mar 24, 2022 | F127328 |
D2312248 | Certificate of Analysis | Mar 24, 2022 | F127328 |
D2312210 | Certificate of Analysis | Mar 24, 2022 | F127328 |
B2328185 | Certificate of Analysis | Mar 24, 2022 | F127328 |
Solubility | Soluble in DMSO (5 mg/ml), ethanol, methanol, and Chloroform.Insolule in water. |
---|---|
Specific Rotation[α] | -17° |
Melt Point(°C) | 224.0 to 228.0°C |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H312:Harmful in contact with skin |
Precautionary Statements | P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P501:Dispose of contents/container to ... P362+P364:Take off contaminated clothing and wash it before reuse. P317:Get emergency medical help. |
WGK Germany | 3 |
RTECS | QL6150000 |
Merck Index | 2476 |
Starting at $86.90
1. Gao Rongyin, Zhang Ximei, Zou Kun, Meng Duo, Lv Jinpeng. (2023) Cryptochrome 1 activation inhibits melanogenesis and melanosome transport through negative regulation of cAMP/PKA/CREB signaling pathway. Frontiers in Pharmacology, 14 [PMID:36814484] |
2. Fangwei Yang, Yixuan Li, Yunfei Xie, Weirong Yao, Fazheng Ren. (2022) Diethyl phosphate disrupts hypothalamus-pituitary-adrenal axis endocrine hormones via nuclear receptors GR and Nur77: Integration of evidences from in vivo, in vitro and in silico approaches. SCIENCE OF THE TOTAL ENVIRONMENT, 844 (157015). [PMID:35777568] |
3. Ye-ying Jiang, Rong-yun Wei, Kai Tang, Zhen Wang, Ning-hua Tan. (2022) Ginsenoside Rg1 promotes neurite growth of retinal ganglion cells through cAMP/PKA/CREB pathways. Journal of Ginseng Research, [PMID:38465221] |
1. Aslostovar L et al.. (2021) Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients.. Cell Rep Med, 2 (2): (100202). [PMID:33665638] |
2. Gomes C et al.. (2013) Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia.. J Neuroinflammation, 10 (16). [PMID:23363775] |
3. Brown LM et al.. (2014) Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors.. J Biol Chem, 289 (42): (29148-57). [PMID:25183009] |
4. Tyurin-Kuzmin PA et al.. (2016) Activation of ß-adrenergic receptors is required for elevated a1A-adrenoreceptors expression and signaling in mesenchymal stromal cells.. Sci Rep, 6 (32835). [PMID:27596381] |
5. Sakai Y et al.. (2021) BRCA1-BARD1 Regulates Axon Regeneration in Concert with the Gqa-DAG Signaling Network.. J Neurosci, 41 (13): (2842-2853). [PMID:33593852] |
6. Hu S et al.. (2019) Caffeine programs hepatic SIRT1-related cholesterol synthesis and hypercholesterolemia via A2AR/cAMP/PKA pathway in adult male offspring rats.. Toxicology, 418 (11-21). [PMID:30825513] |
7. Evans RC et al.. (2015) Calcium-dependent inactivation of calcium channels in the medial striatum increases at eye opening.. J Neurophysiol, 113 (7): (2979-86). [PMID:25673739] |
8. Carlyle BC et al.. (2014) cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex.. Proc Natl Acad Sci U S A, 111 (13): (5036-41). [PMID:24707050] |
9. Bayliss AL & Evans PD. (2013) Characterisation of AmphiAmR11, an amphioxus (Branchiostoma floridae) D2-dopamine-like G protein-coupled receptor.. PLoS One, 8 (11): (e80833). [PMID:24265838] |
10. Gandia J et al.. (2008) Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique.. FEBS Lett, 582 (20): (2979-84). [PMID:18675812] |
11. Luchkina NV et al.. (2014) Developmental switch in the kinase dependency of long-term potentiation depends on expression of GluA4 subunit-containing AMPA receptors.. Proc Natl Acad Sci U S A, 111 (11): (4321-6). [PMID:24599589] |
12. Sampieri L et al.. (2021) CREB3L2 Modulates Nerve Growth Factor-Induced Cell Differentiation.. Front Mol Neurosci, 14 (650338). [PMID:34421533] |
13. Abutaleb NO & Truskey GA. (2021) Differentiation and characterization of human iPSC-derived vascular endothelial cells under physiological shear stress.. STAR Protoc, 2 (2): (100394). [PMID:33796871] |
14. Wang L et al.. (2016) Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance.. J Lipid Res, 57 (7): (1243-55). [PMID:27220352] |
15. Chen J et al.. (2016) Cyp2aa9 regulates haematopoietic stem cell development in zebrafish.. Sci Rep, 6 (26608). [PMID:27197559] |
16. Witkowski G et al.. (2012) Effect of cyclic adenosine monophosphate on the G protein-dependent inward rectifier K(+)-like channel current in medial prefrontal cortex pyramidal neurons.. J Physiol Pharmacol, 63 (5): (457-62). [PMID:23211299] |
17. Tazi MF et al.. (2016) Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.. Autophagy, 12 (11): (2026-2037). [PMID:27541364] |
18. Xiong G et al.. (2022) FOSL1 promotes tumor growth and invasion in ameloblastoma.. Front Oncol, 12 (900108). [PMID:36185257] |
19. Godoy V et al.. (2014) Functional crosstalk between the adenosine transporter CNT3 and purinergic receptors in the biliary epithelia.. J Hepatol, 61 (6): (1337-43). [PMID:25034758] |
20. Miete C et al.. (2022) Gai2-induced conductin/axin2 condensates inhibit Wnt/ß-catenin signaling and suppress cancer growth.. Nat Commun, 13 (674). [PMID:35115535] |
21. Chiang HS et al.. (2014) GEF-H1 controls microtubule-dependent sensing of nucleic acids for antiviral host defenses.. Nat Immunol, 15 (63-71). [PMID:24270516] |
22. Li N et al.. (2018) Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.. Oncogene, 37 (31): (4313-4333). [PMID:29720725] |
23. Brown LM et al.. (2014) Identification and validation of modulators of exchange protein activated by cAMP (Epac) activity: structure-function implications for Epac activation and inhibition.. J Biol Chem, 289 (12): (8217-30). [PMID:24497631] |
24. Lanore F et al.. (2010) Impaired development of hippocampal mossy fibre synapses in mouse mutants for the presynaptic scaffold protein Bassoon.. J Physiol, 588 (Pt 12): (2133-45). [PMID:20421286] |
25. Feng S et al.. (2020) Large-scale Generation of Functional and Transplantable Hepatocytes and Cholangiocytes from Human Endoderm Stem Cells.. Cell Rep, 33 (10): (108455). [PMID:33296648] |
26. Hashimotodani Y et al.. (2017) LTP at Hilar Mossy Cell-Dentate Granule Cell Synapses Modulates Dentate Gyrus Output by Increasing Excitation/Inhibition Balance.. Neuron, 95 (4): (928-943.e3). [PMID:28817805] |
27. Martin C et al.. (2018) NaV1.9 Potentiates Oxidized Phospholipid-Induced TRP Responses Only under Inflammatory Conditions.. Front Mol Neurosci, 11 (7). [PMID:29410612] |
28. Gete YG et al.. (2021) Mechanisms of angiogenic incompetence in Hutchinson-Gilford progeria via downregulation of endothelial NOS.. Aging Cell, 20 (7): (e13388). [PMID:34086398] |
29. Jia Q et al.. (2022) Novel GSK-3 kinase inhibitor Pym-5 induces GSK-3β rather than GSK-3α-dependent melanogenesis in murine melanoma cells.. J Dermatol Sci, 106 (3): (170-180). [PMID:35641396] |
30. Ilhan R et al.. (2022) Novel regulation mechanism of adrenal cortisol and DHEA biosynthesis via the endogen ERAD inhibitor small VCP-interacting protein.. Sci Rep, 12 (869). [PMID:35042898] |
31. Briddon SJ et al.. (2008) Plasma membrane diffusion of G protein-coupled receptor oligomers.. Biochim Biophys Acta, 1783 (12): (2262-8). [PMID:18691614] |
32. Toyohara T et al.. (2020) Patient hiPSCs Identify Vascular Smooth Muscle Arylacetamide Deacetylase as Protective against Atherosclerosis.. Cell Stem Cell, 27 (147-157.e7). [PMID:32413331] |
33. Wang S et al.. (2012) Pericytes regulate vascular basement membrane remodeling and govern neutrophil extravasation during inflammation.. PLoS One, 7 (9): (e45499). [PMID:23029055] |
34. Musante V et al.. (2017) Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition.. Elife, 6 [PMID:28613156] |
35. Fenton RA et al.. (2014) Renal Phosphate Wasting in the Absence of Adenylyl Cyclase 6.. J Am Soc Nephrol, [PMID:24854272] |
36. Lesiak AJ et al.. (2015) RiboTag is a flexible tool for measuring the translational state of targeted cells in heterogeneous cell cultures.. Biotechniques, 58 (6): (308-17). [PMID:26054767] |
37. Gambino F et al.. (2010) Synaptic maturation at cortical projections to the lateral amygdala in a mouse model of Rett syndrome.. PLoS One, 5 (7): (e11399). [PMID:20625482] |
38. McMacken G et al.. (2018) The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes.. Hum Mol Genet, 27 (9): (1556-1564). [PMID:29462491] |
39. Gao Rongyin, Zhang Ximei, Zou Kun, Meng Duo, Lv Jinpeng. (2023) Cryptochrome 1 activation inhibits melanogenesis and melanosome transport through negative regulation of cAMP/PKA/CREB signaling pathway. Frontiers in Pharmacology, 14 [PMID:36814484] |
40. Fangwei Yang, Yixuan Li, Yunfei Xie, Weirong Yao, Fazheng Ren. (2022) Diethyl phosphate disrupts hypothalamus-pituitary-adrenal axis endocrine hormones via nuclear receptors GR and Nur77: Integration of evidences from in vivo, in vitro and in silico approaches. SCIENCE OF THE TOTAL ENVIRONMENT, 844 (157015). [PMID:35777568] |
41. Ye-ying Jiang, Rong-yun Wei, Kai Tang, Zhen Wang, Ning-hua Tan. (2022) Ginsenoside Rg1 promotes neurite growth of retinal ganglion cells through cAMP/PKA/CREB pathways. Journal of Ginseng Research, [PMID:38465221] |